News & Press - BioFlorida, Inc.

News & Press

Read about recent events, essential information and the latest community news.

Scientific Advancements
Wednesday, February 28, 2024 (0 Comments - view/add) LiveCare Inc.(OTCMKTS: LVCE) Enters Hypertension Market, Enhancing Healthcare Monitoring for U.S. Ad » LiveCare Inc.(OTCMKTS: LVCE) Enters Hypertension Market, Enhancing Healthcare Monitoring for U.S. Adults February 28,...
Monday, February 26, 2024 (0 Comments - view/add) INSIGHTEC FOCUSED ULTRASOUND NOW COVERED FOR PARKINSON'S DISEASE PALLIDOTOMY IN US » INSIGHTEC FOCUSED ULTRASOUND NOW COVERED FOR PARKINSON'S DISEASE PALLIDOTOMY IN US Anthem Blue Cross Blue Shield bec...
Friday, February 23, 2024 (0 Comments - view/add) LifeLink® Tissue Bank and Britecyte® Join Forces to Pioneer Advancements in Adipose Tissue Technolog » LifeLink® Tissue Bank and Britecyte® Join Forces to Pioneer Advancements in Adipose Tissue Technology LifeLink Tiss...
Friday, February 23, 2024 (0 Comments - view/add) Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Thr » Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Dise...
Thursday, February 22, 2024 (0 Comments - view/add) ZyVersa Therapeutics Publishes New White Paper Detailing the Role of Inflammasomes and ASC Specks in » ZyVersa Therapeutics Publishes New White Paper Detailing the Role of Inflammasomes and ASC Specks in Neurological Diseases...
Thursday, February 22, 2024 (0 Comments - view/add) Designs for Health Expands Cardiovascular Health Portfolio with the Launch of Vascanox HP® and Nitri » Designs for Health Expands Cardiovascular Health Portfolio with the Launch of Vascanox HP® and Nitric Oxide Test Strips...
Wednesday, February 21, 2024 (0 Comments - view/add) Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (A » Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (AGAMREE®) Study Results...
Wednesday, February 21, 2024 (0 Comments - view/add) Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Thr » Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging...
Wednesday, February 21, 2024 (0 Comments - view/add) Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid C » Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing t...
Tuesday, February 20, 2024 (0 Comments - view/add) Kimera® Labs Inc publishes novel brain targeting of exosomes in Nature Scientific Reports » Kimera® Labs Inc publishes novel brain targeting of exosomes in Nature Scientific Reports MIRAMAR, Fla., Feb. 20,...
Friday, February 16, 2024 (0 Comments - view/add) Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma » Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma PDF Version...
Thursday, February 15, 2024 (0 Comments - view/add) DoseMe Expands Vancomycin Hemodialysis Model » DoseMe Expands Vancomycin Hemodialysis Model February 15, 2024 09:00 AM Eastern Standard Time JUPITER, Fla.--( B...
Thursday, February 15, 2024 (0 Comments - view/add) Getlabs to Add GRAIL's GalleriⓇ Multi-Cancer Early Detection Test to Suite of At-Home Diagnostic Ser » Getlabs to Add GRAIL's Galleri Ⓡ Multi-Cancer Early Detection Test to Suite of At-Home Diagnostic Services MIAMI,&n...
Thursday, February 15, 2024 (0 Comments - view/add) Shamir Medical Center Reveals New Long-Term Results from Long COVID Study to Highlight Positive Impa » Shamir Medical Center Reveals New Long-Term Results from Long COVID Study to Highlight Positive Impact on Symptoms Resulti...
Thursday, February 15, 2024 (0 Comments - view/add) Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published » Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published February 15, 2024 08:...
Wednesday, February 14, 2024 (0 Comments - view/add) AIM ImmunoTech Announces First Subject Dosed in the Netherlands for Phase 1b/2 Study Evaluating Ampl » AIM ImmunoTech Announces First Subject Dosed in the Netherlands for Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) i...
Wednesday, February 14, 2024 (0 Comments - view/add) ZyVersa Therapeutics Highlights Review Article Substantiating That Inflammasome Activation Is Pathog » ZyVersa Therapeutics Highlights Review Article Substantiating That Inflammasome Activation Is Pathogenic in Multiple Neuro...
Tuesday, February 13, 2024 (0 Comments - view/add) Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality » Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanuf...
Tuesday, February 13, 2024 (0 Comments - view/add) Groundbreaking Technology from Base Molecular Resonance™ Technologies Will Change Medical, Security, » Groundbreaking Technology from Base Molecular Resonance™ Technologies Will Change Medical, Security, and Military Sectors...
Monday, February 12, 2024 (0 Comments - view/add) Saama and Pfizer Expand Agreement to Integrate AI-Driven Data Solutions Across R&D Portfolio » Saama and Pfizer Expand Agreement to Integrate AI-Driven Data Solutions Across R&D Portfolio February 12, 2024 07...
Monday, February 12, 2024 (0 Comments - view/add) Resolve Therapeutics Announces Publication of Lupus Clinical Trial Results » Resolve Therapeutics Announces Publication of Lupus Clinical Trial Results MIAMI, Feb. 12, 2024 /PRNewswire/...
Thursday, February 8, 2024 (0 Comments - view/add) Exactech Partners with Statera Medical to Co-Develop World's First Smart Reverse Shoulder Implant » Exactech Partners with Statera Medical to Co-Develop World's First Smart Reverse Shoulder Implant New device designe...
Thursday, February 8, 2024 (0 Comments - view/add) AIM ImmunoTech Reports Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Trea » AIM ImmunoTech Reports Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Co...
Thursday, February 8, 2024 (0 Comments - view/add) Mount Sinai Medical Center First to Utilize AI Technology to Treat Complex Aortic Conditions at Sout » Mount Sinai Medical Center First to Utilize AI Technology to Treat Complex Aortic Conditions at South Florida's Only Aorti...
Tuesday, February 6, 2024 (0 Comments - view/add) Seal Shield Partners with Shyld AI to Revolutionize Healthcare Sanitization with AI and Automation » Seal Shield Partners with Shyld AI to Revolutionize Healthcare Sanitization with AI and Automation JACKSONVILLE, Fla.,...
Tuesday, February 6, 2024 (0 Comments - view/add) Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Comp » Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company February 06,...
Tuesday, February 6, 2024 (0 Comments - view/add) Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm t » Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss As...
Monday, February 5, 2024 (0 Comments - view/add) Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion » Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion February 05, 2024 08:00 AM Eastern Standar...
Friday, February 2, 2024 (0 Comments - view/add) St. Joseph's Children's Hospital First in Tampa Bay to Implant Leadless Pacemaker in Pediatric Heart » St. Joseph's Children's Hospital First in Tampa Bay to Implant Leadless Pacemaker in Pediatric Heart Patient TAMPA,...
Friday, February 2, 2024 (0 Comments - view/add) Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference » Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustain...
Wednesday, January 31, 2024 (0 Comments - view/add) Cadrenal Therapeutics Highlights Publication of Peer-Reviewed Article Supporting Need for New Antico » Cadrenal Therapeutics Highlights Publication of Peer-Reviewed Article Supporting Need for New Anticoagulation Therapy for...
Wednesday, January 31, 2024 (0 Comments - view/add) ZyVersa Therapeutics Highlights Publication Indicating That Inflammasome NLRP3-Mediated Inflammation » ZyVersa Therapeutics Highlights Publication Indicating That Inflammasome NLRP3-Mediated Inflammation in Obese Children Lea...
Tuesday, January 30, 2024 (0 Comments - view/add) Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu » Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Vi...
Tuesday, January 30, 2024 (0 Comments - view/add) Florida Cancer Specialists & Research Institute Contributing to Global Advancements for Treatment of » Florida Cancer Specialists & Research Institute Contributing to Global Advancements for Treatment of Gastrointestinal...
Tuesday, January 30, 2024 (0 Comments - view/add) Tampa General Hospital Is the First and Only in the Southeast to Complete Transcatheter Mitral Valve » Tampa General Hospital Is the First and Only in the Southeast to Complete Transcatheter Mitral Valve Replacement (TMVR) wi...
View "All News Items" »

Member Sign In

Forgot your password?

Don't have a profile?